Australian Technical Advisory Group on Immunisation
| Agency overview | |
|---|---|
| Formed | February 1, 1998[1] |
| Jurisdiction | Australian Government |
| Motto | Advising the Minister for Health on the medical administration of vaccines |
| Employees | 17 members |
| Agency executives |
|
| Parent department | Department of Health |
| Website | health |
The Australian Technical Advisory Group on Immunisation (ATAGI) is the Technical Advisory Group of the Australian Government. As part of the Department of Health, the ATAGI provide advice related to the immunisation program of Australia and other issues related to immunisation to the Minister of Health.[1][2][3]
Roles
ATAGI's role[2]
- The Main role of ATAGI is to provide advisory on the administration of the vaccination related to the National Immunisation Program (NIP) to the Minister of Health
- Advisory on the ongoing immunisation research or the most needed areas
- furnish industry supports with pre-accommodation guidance for likely entries to the Pharmaceutical Benefits Advisory Committee (PBAC) on immunization viability and use in Australia. ATAGI guidance should be looked for before support making an accommodation to the PBAC
- Discussion with pertinent associations to create the Australian Immunization Handbook
- Discussion with significant associations in carrying out vaccination arrangements, strategies and immunization security
Members
| S no. | Position | Name | Start Date | End Date |
|---|---|---|---|---|
| 1 | Chair | A/Prof Christopher Blyth | 1 July 2020 | 30 June 2021 |
| 2 | Chair | Prof. Allen Cheng | 1 July 2020 | 30 June 2021 |
| 3 | Member | Ms. Karen Ballamy | 1 July 2019 | 30 June 2023 |
| 4 | Member | Prof. Tom Snelling | 1 July 2019 | 30 June 2023 |
| 5 | Member | A/Prof Nigel Crawford | 1 July 2019 | 30 June 2023 |
| 6 | Member | James Wood | 14 September 2020 | NA |
| 7 | Member | Dr. Nicholas Silberstein | 1 July 2019 | 30 June 2021 |
| 8 | Member | Prof Katie Flanagan | 1 July 2019 | 30 June 2023 |
| 9 | Member | Assoc Prof Michelle Giles | 1 July 2019 | 30 June 2021 |
| 10 | Member | Ms. Diane Walsh | 14 September 2020 | 30 June 2023 |
| 11 | Member | Ms. Madeline Hall | 1 July 2019 | 30 June 2021 |
| 12 | Member | Ms. Debra Petrys | 1 July 2019 | 30 June 2021 |
| 13 | Member | Kristy Cooper | 25 January 2021 | 30 June 2025 |
| 14 | Member | Prof. Cheryl Jones | 1 July 2019 | 30 June 2023 |
| 15 | Member | Dr. Katherine Gibney | 1 July 2019 | 30 June 2023 |
| 16 | Member | Prof. Bette Liu | 1 July 2019 | 30 June 2023 |
| 17 | Member | Prof. Tony Korman | 1 July 2019 | 30 June 2023 |
Meeting
Australian Technical Advisory Group on Immunisation (ATAGI) often schedule 6 meetings, unless more are needed, according to organised agendas and bulletins for the year.
On 8 April 2021, ATAGI met with the Therapeutic Goods Administration (TGA) regarding the recent concerns of blood clots following administration of the AstraZeneca vaccine. ATAGI advised the government to use the AstraZeneca vaccine only for people over the age of 50.[4][5]
See also
Notes
References
- ^ a b "Australian Technical Advisory Group on Immunisation". Commonwealth of Australia. 9 December 2020. Retrieved 11 April 2021.
{{cite web}}: CS1 maint: url-status (link) - ^ a b "Australian Technical Advisory Group on Immunisation (ATAGI)". Department of Health. 18 March 2021. Retrieved 11 April 2021.
{{cite web}}: CS1 maint: url-status (link) - ^ "Australian Technical Advisory Group on Immunisation (ATAGI)". Melbourne Vaccine Education Centre. October 2020. Retrieved 11 April 2021.
{{cite web}}: CS1 maint: url-status (link) - ^ Australian Government, Department of Health (8 April 2021). "ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns". Australian Technical Advisory Group on Immunisation. Retrieved 9 April 2021.
- ^ "AstraZeneca vaccine: How new advice means total REPLAN of vaccine rollout". 7news. 8 April 2021. Retrieved 11 April 2021.